Merck KGaA (LON:0O14)

Market Cap	40.77B
Revenue (ttm)	18.19B
Net Income (ttm)	2.45B
Shares Out	n/a
EPS (ttm)	5.65
PE Ratio	16.61
Forward PE	12.48
Dividend	1.87 (1.72%)
Ex-Dividend Date	Apr 28, 2025

Volume	33,098
Average Volume	50,092
Open	108.48
Previous Close	109.00
Day's Range	107.65 - 108.90
52-Week Range	100.90 - 176.85
Beta	0.63
RSI	41.66
Earnings Date	Aug 7, 2025

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment also provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and test...

• Industry: Pharmaceutical Preparations
• Founded: 1668
• Employees: 59,020
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O14

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.

Financial numbers in EUR